Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…
Editor's Note Reducing the negative influence of implicit bias requires system-level interventions to ensure procedures align with best practices for all patients, according to results of new research on outcomes for vascular surgery patients. Published February 26 in JAMA Surgery, the study showed that implicit racial bias among vascular specialists…
Editor's Note A September 2024 study, published in the Journal of the American College of Cardiology, found that subclinical atherosclerosis progression in asymptomatic individuals is strongly linked to increased risk of death from any cause, CathLab Digest September 30 reports. The study, led by Mount Sinai Fuster Heart Hospital researchers,…
Editor's Note The American College of Surgeons (ACS) and the Society for Vascular Surgery (SVS) have come together to release new standards for outpatient vascular centers aimed at enhancing the quality of care provided to patients receiving vascular surgical and procedural treatments, an ACS September 19 press release reports. These…
Editor's Note The American College of Surgeons (ACS) and Society for Vascular Surgery (SVS), on March 23, announced the launch of a National Quality Verification Program for Vascular Care (Vascular-VP). Vascular-VP helps participating hospitals improve outcomes and deliver the best treatment for patients having inpatient vascular surgical and interventional procedures.…
Editor's Note This study from Sweden finds that sleeping less than 5 hours a night is associated with an increased likelihood of developing peripheral artery disease (PAD), compared with sleeping 7 to 8 hours. The study included more than 650,000 participants and was conducted in two parts. The first analyzed…